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Abstract A signalling molecularly imprinted polymer was
synthesised for easy detection of tamoxifen and its metabo-
lites. 6-Vinylcoumarin-4-carboxylic acid (VCC) was synthe-
sised from 4-bromophenol to give a fluorescent monomer,
designed to switch off upon binding of tamoxifen. Clomi-
phene, a chlorinated analogue, was used as the template for
the imprinting, and its ability to quench the coumarin fluores-
cence when used in a 1:1 ratio was demonstrated. Tamoxifen
and 4-hydroxytamoxifen were also shown to quench couma-
rin fluorescence. Imprinted and non-imprinted polymers were
synthesised using VCC, methacrylic acid as a backbone
monomer and ethylene glycol dimethacrylate as cross-linker,
and were ground and sieved to particle sizes ranging between
45 and 25 μm. Rebinding experiments demonstrate that the
imprinted polymer shows very strong affinity for both clomi-
phene and tamoxifen, while the non-imprinted polymer shows
negligible rebinding. The fluorescence of the imprinted poly-
mer is quenched by clomiphene, tamoxifen and 4-
hydroxytamoxifen. The switch off in fluorescence of the
imprinted polymer under these conditions could also be de-
tected under a UV lamp with the naked eye, making this
matrix suitable for applications when coupled with a sample
preparation system.
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Introduction
Tamoxifen belongs to a family of drugs known as selective
oestrogen receptor modulators (SERM), which are
characterised by agonist or antagonist activity depending on
the different tissues. Clinically, tamoxifen is widely used for
the treatment of breast cancer, as it acts as antagonist by com-
petitively binding to the oestrogen receptors in the breast,
preventing further production of tissue and effectively stop-
ping tumours’ growth [1]. However for the past 15 years,
tamoxifen has been classified as a prohibited substance by
the World Anti-doping Authority (WADA) and the Interna-
tional Olympic Committee (IOC); as a result of its antagonist
activity in breast tissues, this drug has been inappropriately
used by athletes to mask the side effects of using growth
hormones and anabolic androgenic steroids (AAS), well
known for causing gynecomastia, i.e. enlargement of breast
in man [2]. The exposure of such drug’s abuse requires fre-
quent testing of large numbers of biological samples during
sporting events, which is currently not easily achievable.
Detection of tamoxifen and its metabolites is mainly
achieved via LC-MS and GC-MS after lengthy hydrolysis,
extraction and derivatisation steps [3, 4]. The hydrolysis step
is required due to the fact that 95 % of tamoxifen and its
metabolites in urine are conjugated to glucuronic acid [5],
which makes direct HPLC-UV analysis difficult due to co-
elution peaks. 4-Hydroxytamoxifen and 4-hydroxy-3-
methoxytamoxifen, two of the main metabolites, do exist in
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urine [6] but in very low concentrations (10 ng/ml) [7]. Sam-
ple preparation with molecularly imprinted polymers (MIP)
before HPLC-UV analysis has been demonstrated [7] and al-
lows extraction and enrichment of tamoxifen and tamoxifen
polar metabolites with good clean up performance, where the
main interferences are removed, compared to other SPE
methods. Other methods have also been investigated, and
these include flow cytometry [8], video mass spectrometry
[9], zero current potentiometry to monitor drug interactions
with DNA [10], ultraviolet or fluorescence detection of
photocyclisation products [11] and liquid scintillation
counting [12]. All these methods require complex instrumen-
tation and highly skilled staff and do not allow screening of
large number of samples. There is a clear interest in the devel-
opment of a detection system that could allow a fast pre-
screening of larger number of samples, significantly reducing
the costs while also acting as a deterrent.
Molecular imprinting uses a casting procedure to allow the
formation of three-dimensional cavities in a polymer matrix,
with specific recognition properties. MIPs have been devel-
oped in sample preparation prior to HPLC-UV analysis to
ensure efficient extraction and enrichment of tamoxifen and
its polar metabolites following the hydrolysis step [7] and the
stability of the matrix to harsh environments offers an inter-
esting alternative to proteins.
We report here the development of a new MIP for the
detection of tamoxifen that contains a smart coumarin-
based fluorescent tag that can be quenched upon binding
to tamoxifen and 4-hydroxytamoxifen, to be potentially
used in association with the SPE system for preparation
of the sample. The imprinted polymers show a very good
imprinting efficiency, above 20, compared to the non-
imprinted matrix, and also the ability to recognise not




4-Bromophenol (97 %), triphenylphosphine (99 %), tris(-
dibenzylideneacetone)dipalladium(0) (97 %), extra dry on
molecular sieves tetrahydrofuran (THF) (99.5 %), 2,2′-
azobis(2-methylpropionitrile) (99 %) (AIBN), extra dry on
molecular sieves dichloromethane (DCM) (99.8 %) and ethyl
acetate (99 %) were all purchased from Acros Organic (Geel,
Belgium). Dimethyl acetylenedicarboxylate 98 %, triphenyl
arsine (98 %) and tributyl(vinyl)tin (96 %) were all purchased
from Alfa Aesar (Karlsruhe, Germany). Magnesium sulphate
(98 %), ethanol (99.5 %), sodium hydroxide and concentrated
hydrochloric acid (37 %) were supplied by Carlo Erba (Val de
Reuil, France.). Sodium fluoride (99 %), sodium chloride
(98 %), methacrylic acid (MMA) (99 %), clomiphene citrate
(analytical standard 42 % cis and 58 % trans), 4-hydroxy
tamoxifen (>70%) and EGDMA (98 %) were purchased from
Sigma Aldrich (France and UK). Tamoxifen citrate (99 %)
was purchased from LKT lab Inc. Acetonitrile (99.9 %)
(ACN) was obtained from Fischer Chemicals; acetic acid
(99.7 %) and methanol (99.9 %) were all HPLC grade and
supplied by Carlo Erba (Val de Reuil, France). AIBN was
recrystallised from methanol before use. Clomiphene and ta-
moxifen were isolated from their corresponding citrate salts
using sodium bicarbonate (10 mM) and extracted with DCM.
Falcon 96-microplates were purchased from SLS.
Synthesis of methyl 6-bromocoumarin-4-carboxylate
4-Bromo-phenol (18.26 g, 0.11 mol) and triphenylphosphine
(27.66 g, 0.11 mol) were dissolved in dry DCM (100 ml) and
coo l ed i n a s a l t / i c e ba t h t o −5 °C . D ime thy l
acetylenedicarboxylate (15 g, 0.11 mol) was added to the
mixture drop-wise under nitrogen. On addition, the solution
immediately turned red. The mixture was stirred at −5 °C for
1 h before being refluxed at 40 °C for approximately 100 h.
The solvent was evaporated and the red/brown residue was
recrystallised from ethanol. The orange precipitate was fil-
tered off under suction and rinsed with ethanol to give a
creamy/pale yellow solid. The product was purified on silica
via automated flash chromatography (95:5 DCM, petroleum
ether) giving the desired product with a 25 % yield. The 6-
bromocoumarin 4-carboxylate was confirmed by HPLC-MS
m/z (M +H)++: 285 at 18.2 min.
Synthesis of methyl 6-vinylcoumarin-4-carboxylate
6-Bromocoumarin 4-carboxylate (6.82 g, 24 mmol) and
triphenyl arsine (1.48 g, 4.8 mmol) were dissolved in dry
THF (100 ml) and the palladium catalyst (550 mg, 0.6 mmol)
was added to the mixture under nitrogen. The mixture was
stirred for 10 min, before adding tributyl(vinyl)tin (8.8 ml,
9.54 g, 30 mmol) and refluxing for 125 h at 70 °C. The reac-
tion solution was left to cool to room temperature before
adding 35 ml saturated sodium fluoride solution and 17 ml
distilled water and stirring for 1 h. Following filtration, the
solution was extracted with DCM (2 × 50 ml) and washed
with saturated salt solution (2 × 50 ml). The extracts were
dried over magnesium sulphate, filtered and evaporated under
suction. The solid crude product was purified on silica via
automated flash chromatography using an eluent of 5:95 ethyl
acetate/DCM to give the desired product as a yellow solid
(49 % yield). Purity of methyl 6-vinylcoumarin-4-
carboxylate was confirmed via HPLC-MS: m/z (M +H)+++:
233 at 17.9 min.
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Synthesis of 6-vinylcoumarin-4-carboxylic acid (VCC)
Methyl 6-vinylcoumarin-4-carboxylate (3.1 g, 13 mmol) was
dissolved in a solution of 42 ml THF and 108 ml ethanol.
Sodium hydroxide (25 ml, 2 M) was added to the reaction
and the solution was heated (to 40 °C) under nitrogen for
24 h. Solvents were removed under vacuum and 60 ml of
water were added to the residue, which was washed with
DCM (2 × 100 ml) and ethyl acetate (2 × 100 ml), before being
acidified with concentrated hydrochloric acid. The aqueous
phase was then extracted with ethyl acetate (3 × 50 ml) and
the combined organise phase washed with a saturated NaCl
solution (2 × 50 ml). The organic phase was dried over magne-
sium sulphate and evaporated to dryness to give 6-
vinylcoumarin-4-carboxylic acid (96 % yield). HPLC-MS
m/z (M + H)+++: 219 at 13.9 min. 1H-NMR δ(ppm)
(400 MHz, DMSO): 8.18 (1H, d, J = 2), 7.84 (1H, dd, J = 8,
2) 7.44 (1H, d, J = 8), 6.85 (1H, s), 6.84 (1H, dd, J = 18, 11),
5.86 (1H, d, J = 18), 5.35 (1H, d, J = 11) 13C-NMR δ( ppm)
(400 MHz, DMSO): 165.3(1C), 159.5 (1C), 153.3 (1C), 143.9
(1C), 135.3 (1C), 133.6 (1C), 129.5 (1C), 124.5 (1C), 118.1
(1C), 117.2 (1C), 115.8 (1C) 115.2 (1C).
Synthesis of polymers
6-Vinylcoumarin-4-carboxylic acid (1.1 mmol), MMA
(3.34 mmol), ethylene glycol dimethacrylate (EDGMA;
22.2 mmol) and clomiphene (1.1 mmol, for the MIP) were
dissolved in dry acetonitrile to give a clear solution
(>10 ml). Nitrogen was bubbled through the mixture for
10 min, followed by the addition of AIBN (0.20 mmol). The
sealed flask was placed in an oil bath at 50 °C for 2 days. The
solid material was ground into large chunks and was extracted
five times using an eluent of 92.5 % methanol, 2.5 % water,
5 % acetic acid and then washed two further times with 100 %
methanol. The material was subsequently ground and sieved
between 80 and 45 μm before being extracted and washed
again with the same eluent.
Characterization of the imprinting factor
by chromatography
The MIP and non-imprinted polymer (NIP) bulk polymers
were further ground and sieved to between 45 and 25 μm.
Approximately 300 mg of polymer was sonicated in 16 ml
chloroform and 4 ml of methanol before being packed into a
column (GraceSmart RP18 3u (150 × 2.1 mm)) with metha-
nol. The columns were pre-conditioned with ACN for 1 h
before injecting 1 and 10 mM solutions of clomiphene and
tamoxifen into each column. The columns were eluted with a
5.5 % acidic aqueous solution (comprising 580 μl acetic acid
in 500 ml water, brought to pH 4 with sodium hydroxide) in
ACN. Flow rate was 1 ml/min, column UV detection at
254 nm, operating at 21 °C. Each injection was repeated in
triplicate. The IF was calculated using the following equa-
tions, where t is the retention time of the analyte, t0 is the





Fluorescence quenching of VCC with analytes
The fluorescence measurements were carried out on a
FluoroMax-3 fluorimeter. Excitation wavelength was
345 nm, emission at 521 nm with emission slit 1.5. A
5.93 × 10−4 M stock solution of VCC, a 1.48 × 10−2 M stock
solution of tamoxifen and clomiphene and a 5.16 × 10−3 M
stock solution of 4-hydroxytamoxifen were prepared in
acetonitrile.
To 1 ml of VCC stock solution, the appropriate volume of
analyte solution (to give 0.5, 0.75 and 1 eq) was added follow-
ed by addition of ACN to give a total volume of 2 ml. The
solutions were kept at room temperature for 5 min and the
fluorescence was thenmeasured. Each experiment was repeat-
ed in triplicates and the average of the three datasets was used,
presented together with the standard deviation.
Fluorescence quenching of MIP with analytes
The fluorescence measurements were carried out on a
FLUOstar OPTIMA plate reader. The number of intervals
was set at 150 with 10 flashes per well and 2.20 s as interval
time. The excitation filter used was 340-10 and the emission
filter was 510-20 with a gain of 2000. A 5.9 × 10−3 M stock
solution of tamoxifen and clomiphene and a 5.16 × 10−3 M
stock solution of 4-hydroxytamoxifen were prepared in aceto-
nitrile. To 1 mg of MIP, weighted directly into a well, 200 μl
of acetonitrile and the appropriate volume of analyte solution
(to give 0.25, 0.5, 0.75 and 1 eq) were added. The solutions
were kept at room temperature for 5 min and the fluorescence
was then measured. Each experiment was repeated in dupli-
cates and the average of the two data was used, presented
together with the standard deviation.
Instruments and analytical conditions
A Finnigan surveyor HPLC-MS, using hypersil gold reverse
phase (50 × 2.1 mm) column was used for all mass spectrom-
eter measurements of the organic molecules synthesised. The
column was pre-conditioned with 100 % (0.1 %) formic acid
solution. The 0.1 % formic acid solution was pumped through
the column on a gradient with ACN at a rate of 0.2 ml per
minute.
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The Dionex ASE 350 accelerated solvent extraction ma-
chine was used to extract/wash all bulk polymers formed. A
FluoroMx-3 fluorimeter and a FLUOstar OPTIMA plate read-
er were used to perform VCC and MIP fluorescence measure-
ments, respectively. The 1666 slurry packer from Alltech was
used to load the HPLC columns with the MIPs and NIPs that
had been prepared for analysis.
A HPLV-UV Thermofinnigan Spectra Systemwas used for
the determination of the imprinting factor. The retention time
of the clomiphene in the presence of MIP/NIP was obtained
with a mobile phase of 5:95 acetic acid/acetonitrile solution.
Results and discussion
For the purpose of synthesising a molecular imprinted poly-
mer for the detection of tamoxifen (1), the chlorinated ana-
logue clomiphene (2) was chosen as template, as it had been
previously shown by our group to be a good mimic of the
drug.When developing imprinted polymers for analytical pur-
poses, an analogue of the analyte is often used to imprint the
polymer, as this prevents any traces of the drug being found,
as a result of some template remaining enclosed in the poly-
mer matrix and bleeding during analysis [7].
Clomiphene (2) is structurally very similar to the target
analyte tamoxifen (1), with three phenyl groups providing
multiple opportunities for hydrophobic interactions, and the
replacement of the ethyl group with the chlorine atom being
the only structural difference. This is not expected to have a
significant impact on molecular recognition, as the main in-
teractions between template and monomer will derive from
the ionic bond of the tertiary amine in tamoxifen and the
carboxylic acid in the polymer, together with the hydrophobic
interactions derived from π-π stacking. Additionally, studies
were also carried out using 4-hydroxytamoxifen (3), one of
the main metabolites of tamoxifen (Fig. 1).
In order to develop an imprinted polymer that can be used
in an optical sensor for the detection of tamoxifen, a monomer
with specific optical properties that change upon drug binding
was required. The interaction between the template and the
functional monomer in an imprinted polymer plays a key role
in determining the specificity and rebinding characteristics of
the cavities. These interactions can take the form of covalent,
semi-covalent or non-covalent bonds such as dipole-dipole
interactions, hydrogen bonding, electrostatic interactions and
Van der Waals forces. Although in general the stronger the
interactions are, the higher the imprinting efficiency is, suc-
cessful imprinted polymers have been obtained relying only
on low energy interactions like hydrogen bonds [13].
6-Vinylcoumarin-4-carboxylic acid was selected as func-
tional monomer for this work, as it satisfied two important
requirements: (i) the presence of the COOH group, which
allows strong ionic interactions to take place with the tertiary
amine unit of tamoxifen, 4-hydroxytamoxifen and clomi-
phene; (ii) the strong fluorescence of the coumarin unit, which
was previously shown to be easily quenched when in contact
with ephedrine [14].
Studies of the interaction
between 6-vinylcoumarin-4-carboxylic acid
and clomiphene, tamoxifen and 4-hydroxytamoxifen
Methacrylic acid (MAA) has been previously shown to have a
broad applicability as a functional monomer inMIPs due to its
ability to act as proton donor as well as a hydrogen bond donor
and acceptor. Electrostatic interactions and hydrogen bonds
play a key role in the binding of the template. Previous work
involving methacrylic acid and tamoxifen demonstrated that
the ionic interaction between the acid group in MAA and the
tertiary amine in tamoxifen played a key role in determining
molecular recognition and rebinding [7]. By analogy, the same
interaction was expected with 6-vinylcoumarin-4-carboxylic
acid which contains a carboxylic group and whose fluorescent
characteristics change when involved in non-covalent bond-
ing (Fig. 2).
The fluorescence quenching of the functional monomer
VCC as a result of its interactions with clomiphene, tamoxifen
and also 4-hydroxytamoxifen was studied. VCC has a strong
fluorescence emission at 521 nm when excited at 345 nm.
Solutions of VCC (5.9 × 10−3 M) were mixed with varying
volumes of analytes stocks in acetonitrile, to give a final
monomer to analytes ratio ranging from 1:0 to 1:1. All the
samples were allowed to mix for 5 min at room temperature
before being analysed. The combined data for all three
analytes are shown in Fig. 3 and are presented as percent of
residual fluorescence following addition of the quencher so-
lution. As the equivalents of analytes are increased from 0 to
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fluorescence. All three analytes are able to quench the VCC
fluorescence, with 1 equivalent resulting in approximately
50 % quenching. It is interesting to observe that the chemical
structure of the analytes clearly has some effect on the inter-
action and the extent of the quenching, with clomiphene
appearing to be the best quencher (54 % quenched) compared
for instance to tamoxifen (40 % quenched), when all the other
experimental conditions are kept constant. This is an impor-
tant factor to be considered when the polymers are evaluated.
Polymer synthesis and binding interaction studies
with clomiphene and tamoxifen
Detection of tamoxifen using a sensor requires recognition
and binding of the analyte to take place in an aqueous envi-
ronment, therefore the polymeric matrix needs to be as hydro-
philic as possible, to facilitate the process. Methacrylic acid
was added to the polymer preparation as the backbone mono-
mer. The presence of the carboxylic groups was expected to
contribute to the binding, as previously demonstrated [7] with-
out any detrimental effect on the fluorescence properties of the
functional monomer.
The chemical structure of the cross-linker and its concen-
tration play a very important role in determining the binding
properties of the imprinted polymers. The higher the percent-
age of cross-linker, the more rigid the polymer structure and
also the cavities are, and the more likely they are to retain their
three-dimensional shape. EDGMA is the molecule of choice
in many imprinted polymers and it was chosen as the cross-
linking agent as it had proved to be well incorporated when
imprinting with clomiphene in previous formulations [7]. The
polymerizations were carried out in acetonitrile, the same sol-
vent that was used for the interaction studies between VCC
and clomiphene, using AIBN as the initiator, polymerising for
2 days at 50 °C.
A number of different polymers were prepared using a
variety of ratio of monomers to crosslinker, with the aim of
maximising the incorporation of the VCC functional mono-
mer while retaining a good degree of cross-linking and solu-
bility. Initial formulations were prepared without any
methacrylic acid; however, the overall solubility of the poly-
mer was not sufficient for the desired applications. Following
a number of attempts, the best imprinted preparation (MIP)
was obtained by using the ratio of 1:1:3:20, T/FM/BM/XL
where T = clomiphene, FM = 6-vinylcoumarin-4-carboxylic
acid, BM =MAA and XL = EDGMA, with 80 % cross-
linker and a 1:1 ratio between clomiphene and VCC. The final
ratio of monomers to porogenic solvent, ACN, was 5:6 (w/v).
The corresponding NIP was prepared under identical condi-
tions but without the presence of the clomiphene template.
At the end of the polymerization reaction, the bulk poly-
mers were broken into large pieces that were washed with a
solution of 2.5 % acetic acid in methanol, to remove the tem-
plate from the MIP. HPLC analysis of the extraction solutions
showed that at this stage 34 % of the template had been re-
moved, suggesting that a large portion of the template was still
inside the matrix. Both set of polymers were subsequently
ground and sieved, with particles between 80 and 45 μm,
before being extracted and washed again with the same eluent,
to ensure the complete removal of all templates. Further grind-
ing was carried out to obtain particles between 45 and 25 μm,
and final HPLC analysis of the extraction solution indicated
that 95 % of the template was removed. The incorporation of
VCC in the polymers was estimated by fluorescence using a
reference line. In order to evaluate the different binding capac-
ities of the polymers towards the analytes, both MIP and NIP
were pressure-loaded each into a chromatography column. A
dilute solution of acetone in ACN was injected into the col-
umn as a void volume marker. Injections of 10 mM solutions
of analyte in ACN allowed binding to take place. Monitoring
of the elution profile in 100 % ACN showed that no template
was being released even after 1 h. When a solution of 5 %
acetic acid in ACN was used, the analytes were successfully
eluted as a result of the disruption to the binding interactions
by the acetic acid. The same experiment was carried out with
clomiphene and tamoxifen on both MIP and NIP columns.
Each injection was repeated in triplicate with SD <5 %. The
imprinting factors (IF) for both template and target analyte
obtained (Table 1) showed the superior rebinding capability
of the MIP.


































Fig. 3 Fluorescence quenching of 6-vinylcoumarin-4-carboxylic acid
monomer (VCC), following the addition of the analytes tamoxifen, 4-
hydroxytamoxifen and clomiphene in different quantities ranging from
0 to 1 equivalent in ACN. Fluorescence spectra recorded at 521 nm
following excitation at 345 nm. [VCC] = 2.97 × 10−4 M, Vtot = 2 ml,
incubation time 5 min, experiments repeated in triplicates
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The data shown in Table 1 indicate that the imprinted poly-
mer has a superior molecular recognition capacity towards clo-
miphene compared to the non-imprinted polymer, with an IF =
21.7. The same polymer shows excellent selectivity also to-
wards tamoxifen, with an imprinting factor of 18.7. Comparison
of MIP rebinding data for clomiphene and tamoxifen demon-
strated that the affinity of the MIP for clomiphene, the cognate
template, is 32 % higher than for tamoxifen, as a result of the
imprinting process, while the NIP has very similar values for
both analytes, showing very little rebinding affinity, with values
of kNIP equal to 2.9 and 2.3, respectively. The data demonstrate
that the imprinting process successfully generated a polymer
matrix with very goodmolecular recognition properties for both
clomiphene and tamoxifen, while the non-imprinted polymer, as
expected, does not appear to rebind significantly any of the
analytes. The next step focused on the characterisation of the
fluorescent properties of the imprinted polymer.
Fluorescence quenching studies with imprinted polymer
In order to study how the fluorescence properties of the VCC
were influenced as a result of being incorporated into the
imprinted matrix, a series of experiments were carried out
using MIP together with tamoxifen, 4-hydroxytamoxifen
and clomiphene. Solutions of the imprinted polymer
(5 mg/ml in ACN) were placed in 96-well plate and various
amounts of analytes were added to give a VCC-analyte ratio
ranging from 0 to 0.25,0.5, 0.75 and 1. The solutions were left
for 5 min after which the residual fluorescence was measured
using a plate reader. The data presented in Fig. 4 for all three
analytes show that the interaction of the polymer with increas-
ing amounts of analytes results in all cases in progressive
quenching of its fluorescence. Interestingly in all cases, the
difference in percentage of fluorescence quenched is consis-
tent with the data previously obtained with VCC alone, with
clomiphene being the strongest quencher, followed by 4-
hydroxytamoxifen and then tamoxifen.
Visual detection of clomiphene withMIP compared to NIP
In order to evaluate the feasibility of using the imprinted poly-
mers as materials for the development of a visual sensor, a
quenching experiment with clomiphene was carried out with
bothMIP and NIP using a standard 365 nmUV light. For each
polymer, four glass vials were prepared containing a suspen-
sion of 2 mg of either MIP or NIP in 400 μl of ACN (5 mg/ml
of polymer, 1.18 × 10−3 M in VCC). To each vial, a combina-
tion of ACN and clomiphene stock solution (1.42 × 10−2 M)
was added to give a total volume of 500 μl and a ratio of VCC
to clomiphene ranging from 1:0 to 1:1. The mixtures were
allowed to stand for 5 min at room temperature and were then
placed under the UV lamp. Figure 5 shows the fluorescence of
the vials. It can be clearly seen that while in the case of MIP
(Fig. 5B) there is evidence of quenching, increasing from 0 to
Table 1 Sample volume 20 μl, flow rate 1 ml/min, column dimension
= 150 mm×2.1 mm. Detection at 254 nm, 21 °C. Void volume marker
was acetone, the retention factor and imprinting factor (IF) were
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Fig. 4 Residual fluorescence ofMIP (5 mg/ml in ACN, 1.18 × 10−3 M in
VCC), following the addition of varying equivalents of analytes
(tamoxifen, 4-hydroxytamoxifen and clomiphene). Fluorescence spectra
recorded at 521 nm following excitation at 345 nm. Data are presented as
percentage of residual fluorescence compared to the control
Fig. 5 Visual detection of clomiphene with NIP (A) and MIP (B) by
using a standard 365 nm UV light (2 mg of polymer in 500 μl of
ACN). From left to right, ratio of fluorophore:clomiphene 1:0, 1:0.5,
1:0.75, 1:1. A shows no significant variation in fluorescence by
increasing the amount of clomiphene, while B shows a clear quenching
of fluorescence passing from 0 to 1 equivalents of clomiphene
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1 equivalents of clomiphene, in the case of NIP the fluores-
cence remains unaltered (Fig. 5A).
Conclusions
In this work, VCC and clomiphene were successfully used with
molecular imprinting to create a ‘smart’switchable polymer, with
fluorescent binding sites able to recognise not only the cognate
substrate clomiphene but also tamoxifen and 4-
hydroxytamoxifen. The imprinted polymer was shown to have
excellent molecular recognition properties in ACN towards clo-
miphene and tamoxifen, with imprinting efficiencies of 21.7 and
18.7, respectively, while the NIP did not show any significant
binding affinity, as determined by HPLC. The study of fluores-
cence quenching of the MIP by clomiphene, tamoxifen and 4-
hydroxytamoxifen show progressive quenching as a function of
increasing analyte concentration in ACN. This is consistent with
data obtained with VCC and the analytes alone. Finally, the MIP
was used for a visual detection test in comparison with the NIP.
The results show that the quenching of theMIP can be seen with
naked eye, while the NIP fluorescence remains unaltered. This
represents a significant first step in creating a visual sensor for
drugs, allowing their presence and potentialmisuse to be detected
and assessed by a lay person. The fact that tamoxifen and its
metabolites are essentially insoluble in water and are found in
urine as conjugates of glucuronic acid means that the hydrolysis
step followed by concentration using SPE, as previous reported,
is a necessary step. The polymer obtained in this work is expect-
ed to work coupled to the SPE cartridge, therefore allowing the
detection of the analytes to occur in acetonitrile, where the bind-
ing is maximised. In order to increase the sensitivity of the poly-
mer, the next step will require the preparation of nano-sized
polymeric particles. By increasing the surface-to-volume ratio
and hence exposing more active sites, a greater quantity of the
smart coumarin tag will be available for the drug to rebind,
therefore providing a lower detection limit.
Acknowledgments This work was funded by the EC via a Marie Curie
IAPP—Industry-Academia Partnerships and Pathways project [FP7
Marie Curie Training Network (IAPP-CT-2009-251307)] and QMUL
(studentship to FM). The authors thank Giorgio Chianello for his help
with preparation of Fig. 5.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
References
1. MacGregor JI, Jordan VC. Basic guide to the mechanisms of anti-
estrogen action. Pharmacol Rev. 1998;50(2):151–96.
2. Baker JS, Graham MR, Davies B. Steroid and prescription medi-
cine abuse in the health and fitness community: a regional study.
Eur J Intern Med. 2006;17(7):479–84. doi:10.1016/j.ejim.2006.
041.010.
3. Mazzarino M, De la Torre X, Di Santo R, Fiacco I, Rosi F,
Botre F. Mass spectrometric characterization of tamoxifene
metabolites in human urine utilizing different scan parame-
ters on liquid chromatography/tandem mass spectrometry.
Rapid Commun Mass Spectrom. 2010;24(6):749–60. doi:10.
1002/rcm.4432.
4. Mazzarino M, Bragano MC, de la Torre X, Molaioni F, Botre F.
Relevance of the selective oestrogen receptor modulators tamoxi-
fen, toremifene and clomiphene in doping field: endogenous ste-
roids urinary profile after multiple oral doses. Steroids.
2011;76(12):1400–6. doi:10.1016/j.steroids.2011.06.005.
5. Mareck-Engelke GSU, Opfermann G, Geyer H, Schänzer W.
Screening for tamoxifen, clomiphene and cyclofenil in dop-
ing analysis. Recent Advances in Doping Analysis,
Proceedings of the 19th Cologne Workshop on Dope
Analysis, Germany. 2002.
6. Mihailescu R, Aboul-Enein HY, Efstatide MD. Identification of
tamoxifen and metabolites in human male urine by GC/MS.
Biomed Chromatogr. 2000;14(3):180–3. doi:10.1002/1099-.
7. Claude B, Morin P, Bayoudh S, de Ceaurriz J. Interest of molecu-
larly imprinted polymers in the fight against doping extraction of
tamoxifen and its main metabolite from urine followed by high-
performance liquid chromatography with UV detection. J
Chromatogr A. 2008;1196:81–8. doi:10.1016/j.chroma.2008.05.
022.
8. Chan LL-Y, Shen D,Wilkinson AR, PattonW, Lai N, Chan E, et al.
A novel image-based cytometry method for autophagy detection in
living cells. Autophagy. 2012;8(9):1371–82. doi:10.4161/auto.
21028.
9. Date S, Mizuno H, Tsuyama N, Harada T, Masujima T. Direct drug
metabolism monitoring in a live single hepatic cell by video mass
spectrometry. Anal Sci. 2012;28(3):201–3. doi:10.2116/analsci.28.
201.
10. Guo XX, Song ZJ, Sun JJ, Song JF. Interaction of calf thymus
dsDNA with anti-tumor drug tamoxifen studied by zero current
potentiometry. Biosens Bioelectron. 2011;26(10):4001–5. doi:10.
1016/j.bios.2011.03.021.
11. Zhu Y-B, Zhang Q, Zou J-J, Yu C-X, Xiao D-W. Optimizing high-
performance liquid chromatography method with fluorescence de-
tection for quantification of tamoxifen and two metabolites in hu-
man plasma: application to a clinical study. J Pharm Biomed Anal.
2008;46(2):349–55. doi:10.1016/j.jpba.2007.10.012.
12. Zhao KD, Singh S, Singh J. Effect of menthone on the in vitro
percutaneous absorption of tamoxifen and skin reversibility. Int J
Pharm. 2001;219(1-2):177–81. doi:10.1016/s0378-5173(01)
00640-8.
13. Bonomi P, Servant A, Resmini M. Modulation of imprinting effi-
ciency in nanogels with catalytic activity in the Kemp elimination. J
Mol Recognit. 2012;25(6):352–60. doi:10.1002/jmr.2180.
14. Nguyen TH, Ansell RJ. Fluorescent imprinted polymer sensors for
chiral amines. Org Biomol Chem. 2009;7:1211–20. doi:10.1039/
B816733H.
Imprinted polymers for the rapid detection of tamoxifen 1861
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
